论文部分内容阅读
目的:探析利凡诺联合米非司酮用于中期引产的临床效果。方法:选取我院2013年至2015年收治疗行中期引产的孕产妇140例,将其分为观察组和对照组,各组70例,观察组采用利凡诺联合米非司酮方案,对照组单纯采用利凡诺,从胎盘排出时间、总产程时间、产妇出血量三个方面比较两组的引产效果。结果:观察组胎盘排出时间为(8.55±5.85)h,总产程(18.50±5.50)h,产妇出血(200.50±75.30)ml。对照组胎盘排出时间为(14.55±6.35)h,总产程(28.50±7.45)h,产妇出血(358.50±75.32)ml,两组相比观察组明显低于对照组,两者差异有统计学意义(P<0.05)。结论:利凡诺联合米非司酮用于中期引产的临床效果优良,可以降低产妇引产中出血及缩短引产时间,值得推广。
Objective: To explore the clinical effect of Rivanol in combination with mifepristone for mid-term induction of labor. Methods: 140 pregnant women who received mid-term induction of labor during the period from 2013 to 2015 in our hospital were selected and divided into observation group and control group, with 70 cases in each group. The observation group was given rivanol combined with mifepristone, Group simply rivanol, from the placenta discharge time, total labor time, maternal blood loss in three aspects compared the two groups of induction of labor. Results: The placenta excretion time in the observation group was (8.55 ± 5.85) h, the total labor (18.50 ± 5.50) h and the maternal hemorrhage (200.50 ± 75.30) ml. The time of placenta discharge in the control group was (14.55 ± 6.35) h, the total production was (28.50 ± 7.45) h, and the bleeding was (358.50 ± 75.32) ml in the control group, the two groups were significantly lower than the control group, the difference was statistically significant (P <0.05). Conclusion: Rivanol combined with mifepristone has a good clinical effect in mid-term induction of labor, which can reduce bleeding and shorten the induction of labor during maternal labor, which is worthy of promotion.